When is human leukocyte antigen (HLA) or deoxyribonucleic acid (DNA) typing indicated in the evaluation of acute myeloid leukemia (AML)?

Updated: May 26, 2020
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Perform human leukocyte antigen (HLA) or DNA typing in patients who are potential candidates for allogeneic transplantation.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!